| RSID | rs11919389 |
| HGVS | NC_000003.12:g.101705614T>C |
| Chromosome | 3 |
| Start position | 101705614 |
| Stop position | 101705614 |
| Associated gene(s) | RPL24, CEP97, NXPE3, ZBTB11 |
| Mutation type | Tagged SNP |
| Reference | T |
| Alternative | C |
| Associated allele | C |
| Associated African Allele Frequency | 0.2855 |
| Consequence | Intergenic |
| Other population frequencies link | ALFA rs11919389 |
| Name | Paper | Description of Comparison | Gene | RSID | Association | Disease Status | MAF | Statistical Odds Ratio | Statistical P-value |
|---|---|---|---|---|---|---|---|---|---|
| Horowitz_2_rs11919389 | Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease | COVID-19 severe vs not hospitalised | RPL24, CEP97, NXPE3, ZBTB11 | rs11919389 | positive | Severe | None | None | 0.029 |
| Paper |
|---|
| Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease |